Figure 1From: Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study Darbepoetin alfa (mcg) ± SD utilization over duration of study in the group that received Darbepoetin alfa. Pre-baseline indicates within 30 days of iron infusion. Baseline indicates the day of iron infusion.Back to article page